Cancer Chemotherapy and Pharmacology

Search all Cancer Chemotherapy and Pharmacology articles

Volume 58, Issue 4

October 2006

18 articles in this issue

Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas
J. Feliu
J. García Sáenz
M. González Barón
Original Article 11 January 2006 Pages: 419 - 426
Phase I and pharmacokinetic study of weekly NV06 (Phenoxodiol™), a novel isoflav-3-ene, in patients with advanced cancer
Paul L. de Souza
Winston Liauw
Laurence G. Howes
Original Article 04 February 2006 Pages: 427 - 433
Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells
Jun Yu
Qing-Long Guo
Xiaotang Wang
Original Article 10 February 2006 Pages: 434 - 443
The skin and hair as surrogate tissues for measuring the target effect of inhibitors of phosphoinositide-3-kinase signaling
Ryan Williams
Amanda F. Baker
Garth Powis
Original Article 17 February 2006 Pages: 444 - 450
The tumor specific cytotoxicity of dihydronitidine from Toddalia asiatica Lam
Hironori Iwasaki
Hirosuke Oku
Masashi Inafuku
Original Article 08 February 2006 Pages: 451 - 459
Additive antitumor effects of gefitinib and imatinib on anaplastic thyroid cancer cells
Junichi Kurebayashi
Sumiko Okubo
Hiroshi Sonoo
Original Article 25 January 2006 Pages: 460 - 470
Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins
Tamer E. Fandy
Rakesh K. Srivastava
Original Article 25 January 2006 Pages: 471 - 477
Distribution of 5-aminolevulinic acid derivatives and induced porphyrin kinetics in mice tissues
Gabriela Di Venosa
Alcira Batlle
Adriana Casas
Original Article 17 February 2006 Pages: 478 - 486
Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine
Søren Astrup Jensen
Jens Benn Sørensen
Original Article 18 January 2006 Pages: 487 - 493
Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea
K. Takasuna
T. Hagiwara
T. Kamataki
Original Article 25 January 2006 Pages: 494 - 503
Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma
Maurizio Cantore
Giovanni Serio
Giammaria Fiorentini
Original Article 22 April 2006 Pages: 504 - 508
Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer
J. R. Kroep
E. F. Smit
G. J. Peters
Original Article 07 March 2006 Pages: 509 - 516
Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism
B. J. Cusack
H. Gambliel
R. D. Olson
Original Article 23 March 2006 Pages: 517 - 526
Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer
J. Feliu
G. Martín
M. Gonzalez-Barón
Original Article 23 March 2006 Pages: 527 - 531
Pharmacokinetics of N-2-chloroethylaziridine, a volatile cytotoxic metabolite of cyclophosphamide, in the rat
Hong Lu
Kenneth K. Chan
Original Article 10 February 2006 Pages: 532 - 539
Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells
Bo Yang
Lingling Fan
Qiaojun He
Original Article 07 March 2006 Pages: 540 - 546
Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells
Lars Petter Jordheim
Carlos M. Galmarini
Charles Dumontet
Original Article 04 February 2006 Pages: 547 - 554
Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial
G. P. Stathopoulos
C. Katis
E. Dimou
Original Article 07 March 2006 Pages: 555 - 560

Volume 58, Issue 4

Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas

Phase I and pharmacokinetic study of weekly NV06 (Phenoxodiol™), a novel isoflav-3-ene, in patients with advanced cancer

Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells

The skin and hair as surrogate tissues for measuring the target effect of inhibitors of phosphoinositide-3-kinase signaling

The tumor specific cytotoxicity of dihydronitidine from Toddalia asiatica Lam

Additive antitumor effects of gefitinib and imatinib on anaplastic thyroid cancer cells

Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins

Distribution of 5-aminolevulinic acid derivatives and induced porphyrin kinetics in mice tissues

Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine

Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma

Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer

Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism

Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer

Pharmacokinetics of N-2-chloroethylaziridine, a volatile cytotoxic metabolite of cyclophosphamide, in the rat

Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells

Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells

Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial

Journal navigation